Bing

SEARCH HISTORY

J.C. Penney Co Inc (NYS:JCP - News) jumped 8.3 percent to $9.12 after Citigroup raised the stock to a "buy" and boosted its price ... La Jolla Pharmaceutical Co (LJPC.O) surged 61 percent to $17.55 after the company said its lead experimental drug to ...
YAHOOSports · ByChuck Mikolajczak · 3/11/2014
La Jolla Pharmaceutical Company Announces Portfolio Reprioritization Published May 07, 2015 La Jolla Pharmaceutical Company Announces First Quarter 2015 Financial Results and Corporate Highlights Published Apr 29, 2015 La Jolla Pharmaceutical …
Bloomberg · 1 day ago
Schleifer wasn’t even runner-up on the compensation list for biotech companies; La Jolla Pharmaceutical Co. /quotes/zigman/14988446 /quotes/nls/ljpc LJPC Chief Executive Dr. George Tidmarsh narrowly beat him out at $30.6 million. ModernHealthcare …
Market Watch Commentary · ByRuss Britt · 5/13/2013
More from Bing News
Common Stock, $0.0001 par value; 100,000,000 shares authorized, 15,250,840 and 15,225,980 shares issued and outstanding at March 31, 2015 and December 31, 2014, respectively 2 2 Series C-1 2 Convertible Preferred Stock, $0.0001 par value; 11,000 …
Wallstreet online · 4/29/2015
What: Shares of biotech developer Puma Biotechnology (NYSE: PBYI ) fell by as much as 13% today as investors backed off from the stock's astronomical run-up of more than 300% yesterday following a clinical trial success of the company's …
The Motley Fool · ByDan Carroll · 7/24/2014
What is one of the strongest signals to indicate that a stock is poised for an excellent path ahead? The answer is simple – insider buying. Insiders are people who have access to certain information about the company that is not leaked to the public.
Guru Focus · 2/22/2015
When a biotech stock has already gained 556% this year, like Intercept Pharmaceuticals (ICPT) has, there’s really only one thing for an analyst to do–raise their price target. And that’s exactly what Citigroup did today with Intercept Pharmaceuticals ...
Barron's · 3/15/2014
On a daily basis BigCharts compares each stock's percentage volume change relative to the stock's average trading volume over the past 50 trading days.
Big Charts · 4/8/2015
Vertex Pharmaceuticals Inc., VRTX 0.02 % one of biotechnology’s most richly valued companies, faces a big test Tuesday in proving it can become consistently profitable and live up to its $30 billion market capitalization. A Food and Drug Administration ...
Wall Street Journal · ByJoseph Walker andJoseph.walker · 5/9/2015
Cramer called that number “eye-opening,” but said the company’s current share prices are based on “hope ... trading fractionally higher at $253.75 per share, has seen its stock advance more than 7-fold in the past year, and 15-fold since ...
Wall Street Pit · ByRon Haruni · 2/27/2014